Statement of Changes in Beneficial Ownership (4)
February 24 2021 - 11:12AM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
FOSTER JAMES C |
2. Issuer Name and Ticker or Trading Symbol
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
[
CRL
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Chairman, President and CEO |
(Last)
(First)
(Middle)
251 BALLARDVALE STREET |
3. Date of Earliest Transaction
(MM/DD/YYYY)
2/22/2021 |
(Street)
WILMINGTON, MA 01887
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock | 2/22/2021 | | M | | 17436 | A | $144.67 | 244605 | D | |
Common Stock | 2/22/2021 | | S(1) | | 1425 | D | $280.6625 (2) | 243180 | D | |
Common Stock | 2/22/2021 | | S(1) | | 2223 | D | $281.6867 (3) | 240957 | D | |
Common Stock | 2/22/2021 | | S(1) | | 5476 | D | $282.4925 (4) | 235481 | D | |
Common Stock | 2/22/2021 | | S(1) | | 4020 | D | $283.5599 (5) | 231461 | D | |
Common Stock | 2/22/2021 | | S(1) | | 4240 | D | $284.5008 (6) | 227221 | D | |
Common Stock | 2/22/2021 | | S(1) | | 52 | D | $285.79 | 227169 | D | |
Common Stock | 2/22/2021 | | F | | 1814 | D | $289.55 | 225355 | D | |
Common Stock | 2/23/2021 | | F | | 1994 | D | $283.59 | 223361 | D | |
Common Stock | 2/23/2021 | | M | | 20295 | A | $109.34 | 243656 | D | |
Common Stock | 2/23/2021 | | S(1) | | 454 | D | $274.8063 (7) | 243202 | D | |
Common Stock | 2/23/2021 | | S(1) | | 1309 | D | $276.0295 (8) | 241893 | D | |
Common Stock | 2/23/2021 | | S(1) | | 1809 | D | $277.0009 (9) | 240084 | D | |
Common Stock | 2/23/2021 | | S(1) | | 1249 | D | $278.0703 (10) | 238835 | D | |
Common Stock | 2/23/2021 | | S(1) | | 925 | D | $279.3143 (11) | 237910 | D | |
Common Stock | 2/23/2021 | | S(1) | | 6474 | D | $279.969 (12) | 231436 | D | |
Common Stock | 2/23/2021 | | S(1) | | 4259 | D | $280.9557 (13) | 227177 | D | |
Common Stock | 2/23/2021 | | S(1) | | 2832 | D | $281.9061 (14) | 224345 | D | |
Common Stock | 2/23/2021 | | S(1) | | 984 | D | $282.7797 (15) | 223361 | D | |
Common Stock | | | | | | | | 19013 | I | 2019 GRAT |
Common Stock | | | | | | | | 20000 | I | 2020 GRAT |
Common Stock | | | | | | | | 340 | I | By Trust |
Common Stock | | | | | | | | 750 | I | By Trust |
Common Stock | | | | | | | | 2250 | I | By Trust |
Common Stock | | | | | | | | 10000 | I | Held By Spouse |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Stock Options (Right to Buy) | $144.67 | 2/22/2021 | | M | | | 17436 | 2/22/2020 | 2/22/2024 | Common Stock | 17436 | $0 | 34872 | D | |
Stock Options (Right to Buy) | $109.34 | 2/23/2021 | | M | | | 20295 | 2/23/2019 | 2/23/2023 | Common Stock | 20295 | $0 | 20296 | D | |
Explanation of Responses: |
(1) | This sale occurred pursuant to a 10b5-1 Trading Plan. |
(2) | This transaction was executed in multiple trades at prices ranging from $280.08 to $280.95. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
(3) | This transaction was executed in multiple trades at prices ranging from $281.31 to $282.07. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
(4) | This transaction was executed in multiple trades at prices ranging from $282.08 to $283.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
(5) | This transaction was executed in multiple trades at prices ranging from $283.09 to $284.07. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
(6) | This transaction was executed in multiple trades at prices ranging from $284.09 to $284.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
(7) | This transaction was executed in multiple trades at prices ranging from $274.48 to $275.455. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
(8) | This transaction was executed in multiple trades at prices ranging from $275.535 to $276.45. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
(9) | This transaction was executed in multiple trades at prices ranging from $276.605 to $277.405. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
(10) | This transaction was executed in multiple trades at prices ranging from $277.5 to $278.43 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
(11) | This transaction was executed in multiple trades at prices ranging from $278.63 to $279.46. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
(12) | This transaction was executed in multiple trades at prices ranging from $279.5 to $280.445 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
(13) | This transaction was executed in multiple trades at prices ranging from $280.5 to $281.47. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
(14) | This transaction was executed in multiple trades at prices ranging from $281.59 to $282.42 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
(15) | This transaction was executed in multiple trades at prices ranging from $282.58 to $282.92 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
FOSTER JAMES C 251 BALLARDVALE STREET WILMINGTON, MA 01887 | X |
| Chairman, President and CEO |
|
Signatures
|
/s/ James C. Foster | | 2/24/2021 |
**Signature of Reporting Person | Date |
Charles River Laboratories (NYSE:CRL)
Historical Stock Chart
From Aug 2024 to Sep 2024
Charles River Laboratories (NYSE:CRL)
Historical Stock Chart
From Sep 2023 to Sep 2024